Round Two: BioMarin Resubmits Hemophilia A Gene Therapy Roctavian In US

Conditional Approval Granted In EU In August

 
• By Mandy Jackson
  
Round 2 neon sign with a Brick Wall Background
BioMarin is making a second attempt at FDA approval • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies